BUNKA CHRISTOPHER 4

4 · Lexaria Bioscience Corp. · Filed Nov 10, 2020

Form 4

Period: 2020-11-06

DirectorChariman/CEO/President/CFO

Transactions

Purchase
common shares
2020-11-09$0.21/sh+37,500$8,063→ 6,379,344 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-09$0.20/sh+10,000$2,025→ 6,389,344 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-09$0.20/sh+6,500$1,307→ 6,413,844 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-09$0.20/sh+22,000$4,391→ 6,435,844 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-10$0.20/sh+6,000$1,199→ 6,451,844 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-10$0.19/sh+25,500$4,799→ 6,477,344 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-06$0.21/sh+60,000$12,306→ 6,341,844 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-09$0.21/sh+10,000$2,129→ 6,399,344 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-09$0.20/sh+8,000$1,600→ 6,407,344 total(indirect: Private Holding Company)
Purchase
common shares
2020-11-10$0.20/sh+10,000$1,950→ 6,445,844 total(indirect: Private Holding Company)

Holdings

Stock Options
Exercise: $0.34From: 2020-04-23Exp: 2025-04-23→ Common Shares (700,000 underlying)
700,000
Warrants
(indirect: Private Holding Company)
Exercise: $0.35From: 2020-05-06Exp: 2025-05-06→ Common Shares (200,000 underlying)
200,000
common shares
7,126,304
common shares
(indirect: Private Holding Company)
6,281,844

Documents

1 file